Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-023061

EVP, Research & CSO sold 7,900 shares at $53.60 ($423,408)

  • EVP, Research & CSO acquired 7,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-23 Exercise or conversion : show line 1 in the form +7,900 $1.53 $12,087 82,100 D
2021-03-23 Sale : show line 2 in the form −7,900 $53.60 $423,408 74,200 D
Open-market sales · 7,900 sh · avg $53.60 · $423,408

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-23 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −7,900 337,555 D
Loading xslF345X03/doc4.xml…